Distribution of transforming growth factor-? isoforms in the mammalian retina

D. H. Anderson; C. J. Guerin; G. S. Hageman; B. A. Pfeffer; K. C. Flanders

doi:10.1002/jnr.490420108

Distribution of transforming growth factor-? isoforms in the mammalian retina

Journal of Neuroscience Research ◽

10.1002/jnr.490420108 ◽

1995 ◽

Vol 42 (1) ◽

pp. 63-79 ◽

Cited By ~ 32

Author(s):

D. H. Anderson ◽

C. J. Guerin ◽

G. S. Hageman ◽

B. A. Pfeffer ◽

K. C. Flanders

Keyword(s):

Growth Factor ◽

Transforming Growth Factor ◽

Mammalian Retina

Download Full-text

Detection of transforming growth factor-beta in sputum from patients with bronchial asthma by eosinophil survival assay and enzyme-linked immunosorbent assay

Clinical & Experimental Allergy ◽

10.1046/j.1365-2222.1996.d01-346.x ◽

1996 ◽

Vol 26 (5) ◽

pp. 557-562 ◽

Cited By ~ 1

Author(s):

T. ADACHI ◽

S. MOTOJIMA ◽

A. HIRATA ◽

T. FUKUDA ◽

N. KIHARA ◽

...

Keyword(s):

Growth Factor ◽

Bronchial Asthma ◽

Immunosorbent Assay ◽

Transforming Growth Factor Beta ◽

Transforming Growth Factor ◽

Enzyme Linked Immunosorbent Assay ◽

Eosinophil Survival ◽

Survival Assay ◽

Growth Factor Beta

Download Full-text

UP‐REGULATION OF TRANSFORMING GROWTH FACTOR BETA‐1 (TGF β 1 ) IN FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS (FSGS). A STUDY OF HUMAN RENAL BIOPSY TISSUE USING COMPETITIVE RT‐PCR, AND IN‐SITU HYBRIDISATION

Nephrology ◽

10.1046/j.1440-1797.2000.0abs6.x ◽

2000 ◽

Vol 5 (3) ◽

pp. A68-A68

Author(s):

Langham R ◽

Egan M ◽

Dowling J ◽

Gilbert R ◽

Thomson N.

Keyword(s):

Growth Factor ◽

Renal Biopsy ◽

Transforming Growth Factor Beta ◽

Transforming Growth Factor ◽

In Situ Hybridisation ◽

Rt Pcr ◽

Focal And Segmental Glomerulosclerosis ◽

Biopsy Tissue ◽

Growth Factor Beta

Download Full-text

Fetuin inhibits the effect of transforming growth factor beta in activated hepatic stellate cells

Gastroenterology ◽

10.1016/s0016-5085(01)80131-1 ◽

2001 ◽

Vol 120 (5) ◽

pp. A27-A27

Author(s):

M VERMA ◽

T PETERSON

Keyword(s):

Growth Factor ◽

Transforming Growth Factor Beta ◽

Hepatic Stellate Cells ◽

Transforming Growth Factor ◽

Stellate Cells ◽

Growth Factor Beta ◽

Activated Hepatic Stellate Cells

Download Full-text

Differential expression of peritoneal transforming growth factor-β1 in patients with and without previous abdominal surgery

Gastroenterology ◽

10.1016/s0016-5085(01)81748-0 ◽

2001 ◽

Vol 120 (5) ◽

pp. A352-A352

Author(s):

K HOBSON ◽

M DEWING ◽

H HO ◽

B WOLFE ◽

K CHO ◽

...

Keyword(s):

Growth Factor ◽

Abdominal Surgery ◽

Differential Expression ◽

Transforming Growth Factor ◽

Transforming Growth Factor Β1 ◽

Previous Abdominal Surgery

Download Full-text

583: Transforming Growth Factor β1 and its Receptors are Related to the Development, Recurrence and Prgression of Human Bladder Cancers

The Journal of Urology ◽

10.1016/s0022-5347(18)34823-7 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 159-159

Author(s):

Wun-Jae Kim ◽

ChangYi Quan ◽

Pil-Du Jeoung ◽

Eun-Jung Kim ◽

Ji-Yeon Kim ◽

...

Keyword(s):

Growth Factor ◽

Transforming Growth Factor ◽

Transforming Growth Factor Β1 ◽

Human Bladder

Download Full-text

603: Prostate Androgen Responsiveness Involve Stromal Transforming Growth Factor-Beta Signaling

The Journal of Urology ◽

10.1016/s0022-5347(18)37865-0 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 160-160

Author(s):

Neil A. Bhowmick ◽

Susan Kasper

Keyword(s):

Growth Factor ◽

Transforming Growth Factor Beta ◽

Transforming Growth Factor ◽

Growth Factor Beta

Download Full-text

Human endometrial transforming growth factor-α: A transmembrane, surface epithelial protein that transiently disappears during the midsecretory phase of the menstrual cycle

Journal of the Society for Gynecologic Investigation ◽

10.1016/s1071-5576(97)00016-6 ◽

1997 ◽

Vol 4 (3) ◽

pp. 160-166 ◽

Cited By ~ 9

Author(s):

L HANSARD ◽

B HEALYGARDNER ◽

A DRAPKIN ◽

R BENTLEY ◽

J MCLACHLAN ◽

...

Keyword(s):

Growth Factor ◽

Menstrual Cycle ◽

Transforming Growth Factor ◽

Transforming Growth Factor Α ◽

Factor Α

Download Full-text

Auto-induction of Transforming Growth Factor-βl (TGF-β1) mRNA in porcine granulosa cells and inhibition by a Mitogen-Activated Protein Kinase (MAPK) kinase inhibitor

Journal of the Society for Gynecologic Investigation ◽

10.1016/s1071-5576(97)86103-5 ◽

1998 ◽

Vol 5 (1) ◽

pp. 45A-45A

Author(s):

Y MAU ◽

H FONG ◽

J DAVIS ◽

J MAY

Keyword(s):

Growth Factor ◽

Protein Kinase ◽

Granulosa Cells ◽

Transforming Growth Factor ◽

Kinase Inhibitor ◽

Mitogen Activated Protein Kinase ◽

Mapk Kinase ◽

Porcine Granulosa Cells ◽

Mitogen Activated Protein ◽

Tgf Β1

Download Full-text

Interleukin-1α, Epidermal Growth Factor, and Transforming Growth Factor-β Exhibit Differential Kinetics on Endothelin-1 Synthesis in Amnion Cells

Journal of the Society for Gynecologic Investigation ◽

10.1016/s1071-5576(97)00102-0 ◽

1998 ◽

Vol 5 (1) ◽

pp. 25-30 ◽

Cited By ~ 2

Author(s):

D McKenna

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Transforming Growth Factor ◽

Transforming Growth Factor Β ◽

Endothelin 1 ◽

Epidermal Growth ◽

Interleukin 1Α

Download Full-text

Perianale Fisteln bei CED: vom Mausmodell zur Klinik

Therapeutische Umschau ◽

10.1024/0040-5930/a001000 ◽

2018 ◽

Vol 75 (5) ◽

pp. 287-294

Author(s):

Michael Scharl

Keyword(s):

Growth Factor ◽

Morbus Crohn ◽

Transforming Growth Factor ◽

Transforming Growth Factor Β ◽

Interleukin 13

Zusammenfassung. Fisteln stellen nach wie vor eine der wichtigsten Komplikationen bei Patienten mit Morbus Crohn dar. Bei mindestens einem Drittel aller Morbus Crohn Patienten treten im Laufe der Erkrankung Fisteln auf. Eine dauerhafte Heilung der Fistel wird jedoch, auch unter Ausschöpfung sämtlicher medikamentöser und chirurgischer Therapieoptionen, nur in rund einem Drittel dieser Patienten erreicht. Der genaue molekulare Mechanismus der Fistelentstehung ist bis heute nicht ganz klar. Aus histopathologischer Sichtweise stellen Fisteln eine röhrenartige Struktur dar, welche von flachen epithelartigen Zellen ausgekleidet ist. Als ursächlicher Entstehungsmechanismus wird dabei die sogenannte epitheliale-zu-mesenchymale Transition (EMT) angesehen und es kann eine starke Expression der Entzündungsmediatoren Tumor Nekrose Faktor, Interleukin-13 und Transforming Growth Factor β in den Fistelarealen nachgewiesen werden. Zusätzlich zu den bereits etablierten, medikamentösen Therapieoptionen, also Antibiotika, Immunmodulatoren und anti-TNF Antikörper, stellt insbesondere der Einsatz der mesenchymalen Stammzelltherapie einen erfolgversprechenden Therapieansatz für die Zukunft dar.

Download Full-text